Sign In
Buy SNN
$31.56
-0.770 (-2.38%)
At Close: Jul 31, 2026
Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair
12:15pm, Wednesday, 21'st Jan 2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of Integrity Orthopaedics, further strengthening its sports medicine shoulder r
LARGE CAP INTERNATIONAL PORTFOLIO Buys 29,670 Shares of Smith & Nephew PLC (SNN)
04:40pm, Monday, 19'th Jan 2026
Summary LARGE CAP INTERNATIONAL PORTFOLIO raised its stake in Smith and Nephew PLC (SNN) by 226.13%, purchasing 29,670 shares to own 42,791 shares valued
SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal
01:35pm, Monday, 19'th Jan 2026
SNN expands its Sports Medicine portfolio with Integrity Orthopaedics, adding next-gen Tendon Seam tech to strengthen leadership in shoulder repair.
UK's Smith & Nephew to buy Integrity Orthopaedics for up to $450 million
12:34pm, Monday, 12'th Jan 2026
British medical products maker Smith & Nephew will buy U.S.-based Integrity Orthopaedics in a deal that could be valued at up to $450 million, the company said on Monday.
Smith & Nephew: Improving And Undervalued, But Mind The Knees
10:47pm, Wednesday, 07'th Jan 2026
Smith & Nephew has outperformed peers, driven by strong sports medicine and wound care, despite ongoing ortho business challenges. SNN's major joints segment remains a sore spot, with ongoing underper
Smith & Nephew SNATS, Inc. $SNN Holdings Trimmed by Deprince Race & Zollo Inc.
04:28am, Monday, 29'th Dec 2025
Deprince Race and Zollo Inc. lowered its holdings in Smith and Nephew SNATS, Inc. (NYSE: SNN) by 37.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exc
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
11:32am, Friday, 12'th Dec 2025
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
05:37pm, Monday, 08'th Dec 2025
Smith & Nephew plc (SNN) Analyst/Investor Day Transcript
Smith & Nephew's ambitious growth plans get sceptical reaction from analysts
07:34am, Monday, 08'th Dec 2025
Smith & Nephew PLC's (LSE:SN) new strategic plan and 2028 outlook look ambitious, City analysts said, but have been received with some heavy dashes of scepticism. UBS, which kept its rating on the s
Smith & Nephew nudges up guidance and unveils new strategic plan
03:04am, Monday, 08'th Dec 2025
Smith & Nephew PLC (LSE:SN) has launched a new corporate strategy designed to give stronger returns for shareholders, alongside issuing medium-term financial targets through to 2028, alongside update
Smith & Nephew boosts 2025 cashflow forecast and unveils medium-term targets
02:22am, Monday, 08'th Dec 2025
British medical products maker Smith & Nephew raised its 2025 free cash flow forecast to around $800 million and unveiled new medium-term targets ahead of its Capital Markets Day Event on Monday.
Head to Head Contrast: Trinity Biotech (NASDAQ:TRIB) vs. Smith & Nephew SNATS (NYSE:SNN)
02:30am, Sunday, 07'th Dec 2025
Trinity Biotech (NASDAQ: TRIB - Get Free Report) and Smith and Nephew SNATS (NYSE: SNN - Get Free Report) are both medical companies, but which is the better investment? We will compare the two busine
Creative Planning Sells 9,885 Shares of Smith & Nephew SNATS, Inc. $SNN
04:03am, Thursday, 27'th Nov 2025
Creative Planning cut its position in shares of Smith and Nephew SNATS, Inc. (NYSE: SNN) by 13.7% in the second quarter, according to the company in its most recent filing with the Securities and Exch
Smith & Nephew steadies expectations as investors look to December
06:24am, Thursday, 13'th Nov 2025
For a business built on orthopaedics and wound care, Smith & Nephew PLC (LSE:SN) has given investors a fair bit of whiplash. Its third-quarter update sent the shares down about 10% after organic reven
Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript
07:16am, Thursday, 06'th Nov 2025
Smith & Nephew plc ( SNN ) Q3 2025 Sales Call November 6, 2025 3:30 AM EST Company Participants Deepak Nath - CEO & Director John Rogers - CFO & Executive Director Conference Call Participants Jack Re
